Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 16 Jul 2026 for CYTOKINETICS INC, €11k. Read the official filing
Filing timeline
BuySaleRobert Arthur Harrington
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert Arthur Harrington: trading record in brief
All filings by Robert Arthur Harrington on record concern Cytokinetics Inc, in the capacity of board member. The record holds 25 filings, for trades running from 10 May 2022 to 15 July 2026.
On the market, this insider has only sold: 6 sales, €350k in total. The rest of the record consists of 19 share grants.
Most recently, on 16 July 2026, the filings show a share grant worth €11k in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Arthur Harrington
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
151 shares@ US$82.620.0001% mcap2.9% of flowCommon StockSEC:0001061983-26-000079:0
2,851 shares0Common StockSEC:0001061983-26-000060:0
191 shares@ US$65.370.0001% mcap100.0% of flowCommon StockSEC:0001061983-26-000038:0
197 shares@ US$63.442.9% of flowCommon StockSEC:0001061983-26-000004:0
2,150 shares@ US$66.8034.4% of flowCommon StockSEC:0001061983-25-000039:0
199 shares@ US$62.804.5% of flowCommon StockSEC:0001061983-25-000013:0
2,150 shares@ US$48.6780.8% of flowCommon StockSEC:0001127602-25-021071:0
328 shares@ US$38.0150.4% of flowCommon StockSEC:0001127602-25-019287:0
7,333 shares0Common StockSEC:0001127602-25-014892:0
324 shares@ US$38.564.9% of flowCommon StockSEC:0001127602-25-012115:0
450 shares@ US$39.437.1% of flowCommon StockSEC:0001127602-25-011689:0
900 shares@ US$42.5016.2% of flowCommon StockSEC:0001127602-25-007902:0
255 shares@ US$48.935.3% of flowCommon StockSEC:0001127602-25-000768:0
237 shares@ US$52.605.0% of flowCommon StockSEC:0001127602-24-025197:0
253 shares@ US$54.615.7% of flowCommon StockSEC:0001127602-24-020198:0
228 shares0Common StockSEC:0001127602-24-020145:0
1,580 shares@ US$48.6431.2% of flowCommon StockSEC:0001127602-24-017963:0
5,600 shares0Common StockSEC:0001127602-24-015723:0
148 shares@ US$84.125.0% of flowCommon StockSEC:0001127602-24-000423:0
448 shares@ US$27.885.3% of flowCommon StockSEC:0001127602-23-025197:0
374 shares@ US$33.365.1% of flowCommon StockSEC:0001127602-23-020043:0
5,000 shares0Common StockSEC:0001127602-23-016164:0
298 shares@ US$37.714.6% of flowCommon StockSEC:0001127602-23-012559:0
253 shares@ US$44.354.7% of flowCommon StockSEC:0001127602-23-000722:0
5,000 shares0Common StockSEC:0001061983-22-000117:0
25 of 25 declarations
